Theravance Biopharma (TBPH) Work In Process (2013 - 2018)
Theravance Biopharma (TBPH) reported Work In Process of $3.6 million for Q3 2018, up 379.89% year-over-year from $756000.0 in Q3 2017, and up 8.33% on a QoQ basis from $3.3 million in Q2 2018.
Theravance Biopharma (TBPH) has 5 years of Work In Process data on file, last reported at $3.6 million in Q3 2018.
- Quarterly Work In Process rose 379.89% year-over-year to $3.6 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $3.6 million (up 379.89% YoY) and the FY2017 annual result came in at $66000.0, down 97.49% from the prior year.
- Work In Process climbed to $3.6 million in Q3 2018 per TBPH's latest filing, from $3.3 million in the prior quarter.
- Across five years, Work In Process topped out at $3.6 million in Q3 2018 and bottomed at $66000.0 in Q4 2017.
- The 4-year median for Work In Process is $2.0 million (2018), against an average of $1.9 million.
- The widest annual swing landed in 2017, when Work In Process slumped 97.49%; it then soared 379.89% in 2018.
- Tracing TBPH's Work In Process over 4 years: stood at $145000.0 in 2014, then surged by 1711.72% to $2.6 million in 2016, then tumbled by 97.49% to $66000.0 in 2017, then surged by 5396.97% to $3.6 million in 2018.
- Per Business Quant, the three latest TBPH Work In Process figures stand at $3.6 million (Q3 2018), $3.3 million (Q2 2018), and $2.0 million (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Theravance Biopharma | 823.54 Mn | 428.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 3.63 Mn |
| Jun 30, 2018 | 3.35 Mn |
| Mar 31, 2018 | 1.99 Mn |
| Dec 31, 2017 | 66,000.00 |
| Sep 30, 2017 | 756,000.00 |
| Jun 30, 2017 | 3.38 Mn |
| Mar 31, 2017 | 2.63 Mn |
| Dec 31, 2016 | 2.63 Mn |
| Sep 30, 2016 | 837,000.00 |
| Jun 30, 2016 | 1.84 Mn |
| Mar 31, 2016 | 1.76 Mn |
| Dec 31, 2014 | 145,000.00 |
| Sep 30, 2014 | 812,000.00 |
| Jun 30, 2014 | 2.28 Mn |
| Mar 31, 2014 | 2.23 Mn |
| Dec 31, 2013 | 360,000.00 |